Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Influenza

Free Subscription 13.10.2025 1 Ann Intern Med 1 Antiviral Res 2 Epidemiol Infect 1 J Epidemiol Community Health 1 J Exp Med 1 J Infect 1 J Virol 5 PLoS Comput Biol 1 PLoS Med 15 PLoS One 2 Proc Natl Acad Sci U S A 19 Vaccine

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Intern Med

1. LE VU M, Matthes KL, Schneider EB, Moerlen A, et al
   Maternal Influenza-Like Illness and Neonatal Health During the 1918 Influenza Pandemic in a Swiss City.
   Ann Intern Med. 2025 Oct 7. doi: 10.7326/ANNALS-24-03796.
   PubMed         Abstract available
   
   

   
   Antiviral Res

2. SCHRELL L, Scheibner D, Dickmanns A, Stegmann KM, et al
   Inhibitors of pyrimidine synthesis synergize with N4-hydroxycytidine to diminish influenza virus replication.
   Antiviral Res. 2025 Oct 3:106286. doi: 10.1016/j.antiviral.2025.106286.
   PubMed         Abstract available
   
   

   
   Epidemiol Infect

3. VAN DER ROEST B, Fischer EAJ, Klinkenberg D, Bootsma MCJ, et al
   Phylodynamic inference suggests introductions as main driver of Mpox Clade II outbreak in 2022 in Slovenia.
   Epidemiol Infect. 2025;153:e115.
   PubMed         Abstract available
   
   
4. WOLDEGIORGIS M, Bloomfield L, Korda R, Cadby G, et al
   Factors associated with persistence or recovery from long COVID 6 months post-SARS-CoV-2 infection.
   Epidemiol Infect. 2025;153:e116.
   PubMed         Abstract available
   
   

   
   J Epidemiol Community Health

5. ROMANO CJ, Nianogo RA, Hoover C, Quint JJ, et al
   Evaluating the effect of the end of the COVID-19 uninsured programme on COVID-19 vaccine administration in California: a quasi-experimental study.
   J Epidemiol Community Health. 2025;79:821-827.
   PubMed         Abstract available
   
   

   
   J Exp Med

6. CHANGROB S, Yasuhara A, Park S, Bangaru S, et al
   Common cold embecovirus imprinting primes broadly neutralizing antibody responses to SARS-CoV-2 S2.
   J Exp Med. 2025;222:e20251146.
   PubMed         Abstract available
   
   

   
   J Infect

7. FOULKES S, Munro K, Sparkes D, Khawam J, et al
   Prevalence and impact of SARS-CoV-2, influenza, respiratory syncytial virus (RSV) infection and respiratory illness on UK healthcare workers during winter 2023/24 (September 2023 to March 2024): SIREN cohort study.
   J Infect. 2025;91:106620.
   PubMed         Abstract available
   
   

   
   J Virol

8. SHETTY N, Shephard MJ, Rockey NC, Macenczak H, et al
   Correction for Shetty et al., "Influenza virus infection and aerosol shedding kinetics in a controlled human infection model".
   J Virol. 2025 Oct 7:e0135425. doi: 10.1128/jvi.01354.
   PubMed        
   
   

   
   PLoS Comput Biol

9. O'NEILL X, White A, Northrup GR, Saad-Roy CM, et al
   Superspreading and the evolution of virulence.
   PLoS Comput Biol. 2025;21:e1013517.
   PubMed         Abstract available
   
   
10. TEITELBAUM CS, Casazza ML, Overton CT, Matchett EL, et al
    Host responses and viral traits interact to shape the impacts of climate warming on highly pathogenic avian influenza in migratory waterfowl.
    PLoS Comput Biol. 2025;21:e1013451.
    PubMed         Abstract available
    
    
11. PINETTES T, Leclerc QJ, Jean K, Temime L, et al
    The quarantine hospital strategy as a way to reduce both community and nosocomial transmission in the context of a COVID-like epidemic.
    PLoS Comput Biol. 2025;21:e1013548.
    PubMed         Abstract available
    
    
12. STEYN N, Chadeau-Hyam M, Elliott P, Donnelly CA, et al
    A Bayesian model for repeated cross-sectional epidemic prevalence survey data.
    PLoS Comput Biol. 2025;21:e1013515.
    PubMed         Abstract available
    
    
13. DU H, Zahn MV, Loo SL, Alleman TW, et al
    Improving policy design and epidemic response using integrated models of economic choice and disease dynamics with behavioral feedback.
    PLoS Comput Biol. 2025;21:e1013549.
    PubMed         Abstract available
    
    

    
    PLoS Med

14. LEWNARD JA, Malden DE, Hong V, Skela J, et al
    Comparative risk of post-acute sequelae among adults following SARS-CoV-2 or influenza virus infection: A retrospective cohort study among United States adults.
    PLoS Med. 2025;22:e1004777.
    PubMed         Abstract available
    
    

    
    PLoS One

15. LOMELI A, Escoto AA, Reyes B, Kornher K, et al
    Sources of successful participant engagement in a public health research study: A focus on a Latino community.
    PLoS One. 2025;20:e0321910.
    PubMed         Abstract available
    
    
16. TITUS AR, Kanchi R, Adhikari S, Thorpe LE, et al
    Time-varying associations between diabetes and mortality following COVID-19: Evidence from a U.S. Veteran population.
    PLoS One. 2025;20:e0333052.
    PubMed         Abstract available
    
    
17. LIU HH, Battaglia J, Wu TT
    Impact of COVID-19 on English Football Premier League: Analyzing rankings and home advantage using extended Bradley-Terry models.
    PLoS One. 2025;20:e0332627.
    PubMed         Abstract available
    
    
18. MILLER EM, Boyce RM, Kipp AM, Newby LK, et al
    Incidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in North Carolina from December 2020 - February 2022.
    PLoS One. 2025;20:e0332645.
    PubMed         Abstract available
    
    
19. REVELJ M, Wessberg A, Carlsson Y, Lindqvist M, et al
    Reclaiming motherhood through shame, distance, and gratitude-A phenomenological study of Swedish women's lived experiences of giving birth while ill with COVID-19.
    PLoS One. 2025;20:e0333937.
    PubMed         Abstract available
    
    
20. LAN WY, Cai SS, Lu Q, Tang F, et al
    Identification of shared key genes in Rheumatoid Arthritis and COVID-19 and their relevance as diagnostic biomarkers and with immune infiltration: New insights from bioinformatics analysis.
    PLoS One. 2025;20:e0333886.
    PubMed         Abstract available
    
    
21. SHOBHA M, Morgan K, Tan MP
    Exploring the social and emotional impact of COVID-19 on older residents of the Greater Klang Valley, Malaysia: A qualitative study.
    PLoS One. 2025;20:e0332610.
    PubMed         Abstract available
    
    
22. DOMINGUES RMSM, Herzog RSA, Dias MAB, Francisco RPV, et al
    Effects of human development, primary care coverage and the COVID-19 pandemic on the fertility rate among adolescents in Brazil in the period 2012-2021.
    PLoS One. 2025;20:e0327656.
    PubMed         Abstract available
    
    
23. GUO L, Jiang L, Huang H
    A longitudinal study of four-year changes in physical fitness among university students before and after COVID-19: 2019-2022.
    PLoS One. 2025;20:e0334088.
    PubMed         Abstract available
    
    
24. BEAUCHAMP M, Farley C, Kirkwood R, Jones A, et al
    Functional recovery 2-years after hospitalization for COVID-19: Insights from the COREG-FR extension study.
    PLoS One. 2025;20:e0334212.
    PubMed         Abstract available
    
    
25. LEE R, Cho J, Bae D, Albers L, et al
    Prospective associations of COVID-related stress with vaping nicotine and cannabis among high school students: Mediated by vaping susceptibility.
    PLoS One. 2025;20:e0334159.
    PubMed         Abstract available
    
    
26. AXEN I, Weiss N, Skillgate E
    Health aspects and lifestyle of licensed manual therapists during the COVID-19 pandemic in Sweden: The CAMP cohort study.
    PLoS One. 2025;20:e0327600.
    PubMed         Abstract available
    
    
27. CHESENG A, Vattanasit U, Kongpran J, Thanapop C, et al
    Environmental health management in local community isolation facilities during COVID-19 pandemic: A case study in Nakhon Si Thammarat, Thailand.
    PLoS One. 2025;20:e0333638.
    PubMed         Abstract available
    
    
28. NGO VK, Vu TT, Sunseri V, Sharma S, et al
    Community's perceptions of the police during COVID-19 in Harlem, New York, a predominantly Black community: Social and geographical dimensions.
    PLoS One. 2025;20:e0329027.
    PubMed         Abstract available
    
    
29. AUSTIN LC, Gomes MN, Chavez S, Degano C, et al
    Foundations under pressure: Qualitative interviews on the impact of prolonged pandemic and public health measures on Ontario youth and young adults.
    PLoS One. 2025;20:e0307423.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

30. MCKELLAR J, Cadenes J, Garcia de Gracia F, Aube C, et al
    Human MX1 orchestrates the cytoplasmic sequestration of neosynthesized influenza A virus vRNPs.
    Proc Natl Acad Sci U S A. 2025;122:e2418935122.
    PubMed         Abstract available
    
    
31. LIU S, Yan L, Du W, Liu W, et al
    Manifold-constrained nucleus-level denoising diffusion model for structure-based drug design.
    Proc Natl Acad Sci U S A. 2025;122:e2415666122.
    PubMed         Abstract available
    
    

    
    Vaccine

32. ROMANOVA J, Krokhin A, Ferko B, Pleimes D, et al
    Protective efficacy of the UniFluVec influenza vaccine vector against the highly pathogenic influenza A/Indonesia/5/2005 (H5N1) strain in ferrets.
    Vaccine. 2025;65:127795.
    PubMed         Abstract available
    
    
33. ANDERSON KM, Nowak GJ, Cacciatore MA, Rohani P, et al
    Understanding influenza vaccination attitudes and behaviors: An assessment of health decision-making preferences.
    Vaccine. 2025;65:127804.
    PubMed         Abstract available
    
    
34. ALMEIDA GG, Pinto JA, Pinto PM, da Silva LB, et al
    Safety and immunogenicity of SpiN-Tec, a T-cell based RBD-Nucleocapsid chimeric vaccine for COVID-19.
    Vaccine. 2025;64:127756.
    PubMed         Abstract available
    
    
35. HUMPHREYS J, Blake A, Nicolay N, Braeye T, et al
    Effectiveness of JN.1 monovalent COVID-19 vaccination in EU/EEA countries between October 2024 and January 2025: a VEBIS electronic health record network study.
    Vaccine. 2025;64:127752.
    PubMed         Abstract available
    
    
36. CUYPERS L, Dambre C, Desmet S
    Exceptional high number of IPD cases in winter season 2024-2025 in Belgium in concomitance with rise in vaccine serotypes.
    Vaccine. 2025;64:127763.
    PubMed         Abstract available
    
    
37. INOUE S, Fuji K
    The mutual cyclical influence of internet information and vaccination intention on post-dissemination vaccination: A longitudinal study during the availability period of COVID-19 booster shots.
    Vaccine. 2025;64:127741.
    PubMed         Abstract available
    
    
38. HAMONIC G, Pastural E, Arora S, Lew J, et al
    Safety and immunogenicity of COVAC-2, a Sepivac SWE adjuvanted SARS-CoV-2 recombinant protein vaccine in healthy adults; a randomized controlled first-in-human dose-escalation trial.
    Vaccine. 2025;64:127748.
    PubMed         Abstract available
    
    
39. TURJEMAN A, Shochat T, Drozdinsky G, Leibovici L, et al
    Disparities and temporal trends in pneumococcal vaccination uptake among older adults in the Israeli population: A population-based retrospective cohort study.
    Vaccine. 2025;64:127765.
    PubMed         Abstract available
    
    
40. VAN BEEK LF, He X, Koks MS, van der Gaast-de Jongh CE, et al
    Comparing the immunogenicity of intradermal and intramuscular vaccination of elderly with BNT162b2 XBB.1.5: An equivalent dose study.
    Vaccine. 2025;64:127749.
    PubMed         Abstract available
    
    
41. HUANG W, Xu M, Diao Z, Chen J, et al
    Vaccination coverage by age 24 months among children born in 2020 and 2021 in China, during the COVID-19 pandemic: A study based on the national immunization information system.
    Vaccine. 2025;64:127717.
    PubMed         Abstract available
    
    
42. YANG Y, Jin SW, Lee S, Lartey S, et al
    Understanding vaccine willingness in post-COVID America: Key determinants and demographic differences.
    Vaccine. 2025;64:127740.
    PubMed         Abstract available
    
    
43. WETZKE M, Lange M, Beinhauer K, Rope E, et al
    Immunization acceptance after broad recommendation for RSV prophylaxis: Results from a cross-sectional study in Germany.
    Vaccine. 2025;64:127716.
    PubMed         Abstract available
    
    
44. DIEMERT DJ, Graciaa DS, Zhang B, Rouphael NG, et al
    Effect of Omicron BA.1-based compared to prototype booster mRNA vaccination on incidence of COVID-19 in the COVAIL trial.
    Vaccine. 2025;64:127718.
    PubMed         Abstract available
    
    
45. BALMUTH A, Brennan T, Ashebir S, D'Ambrosio L, et al
    Examining the contributions of demographic variables to vaccination uptake among the U.S. aged 50.
    Vaccine. 2025;64:127711.
    PubMed         Abstract available
    
    
46. WANG Y, Ni Y, Leung CMC, Ning K, et al
    Longitudinal patterns and predictors of COVID-19 vaccine confidence from pre-vaccine rollout to mass vaccination: A population-based cohort study.
    Vaccine. 2025;64:127736.
    PubMed         Abstract available
    
    
47. ZHAO Y, Zhao Z, Cheng C, Tian M, et al
    A bivalent SARS-CoV-2 subunit vaccine for cats neutralizes both the original ancestral strain and BA.1 Pseudovirus carrying the 453F and 501 T mutation.
    Vaccine. 2025;64:127685.
    PubMed         Abstract available
    
    
48. MUES KE, Zhou CK, Gerber JE, van Hunsel F, et al
    A review of methodologic & data considerations for vaccine safety surveillance in the wake of the COVID-19 pandemic.
    Vaccine. 2025;64:127691.
    PubMed         Abstract available
    
    
49. BOGA DJ, Robinson M, Tirupathi M, Juste RS, et al
    Latent class and time-to-event analyses of social determinants of health and COVID-19 vaccine uptake among Black women living with HIV.
    Vaccine. 2025;64:127649.
    PubMed         Abstract available
    
    
50. ROY DN, Rashid M, Aktar A, Parvin MS, et al
    Potential predictors of COVID-19 booster vaccine confidence among adult people: a cross-sectional analysis amid the Omicron surge in Southern Bangladesh.
    Vaccine. 2025;64:127693.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.